A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) ...

One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.

Analysis suggests stents aren't as beneficial as previously thought. Feb. 28, 2012— -- Inserting stents to open a blocked artery is a common way to treat coronary artery disease. But increasing ...

"TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%" was originally created and published by ...

Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) ...

In the REC-CAGEFREE I trial by Chao Gao and colleagues,1 an open-label, randomised, non-inferiority trial comparing a drug-coated balloon (DCB) with a drug-eluting stent (DES) in patients with de novo ...

CHICAGO.-- Northwestern's Bluhm Cardiovascular Institute recently enrolled its first subject in ABSORB III, a clinical trial to study a "disappearing" heart device for the treatment of coronary artery ...

Nov. 2 (UPI) --For patients with stable angina, coronary artery stents may have more of a placebo effect than previously thought, researchers in England report in a new study. Researchers from the ...

The FDA approved a new emergency stent device to treat perforations in the blood vessels of the heart, the agency’s first new treatment option in the indication in 17 years. Deep tears in coronary ...

Every year, 60,000 people in the UK are diagnosed with heart failure, and many are treated with stents. In a large new study published in the New England Journal of Medicine, my colleagues and I ...